| Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients (NCT05066945) | Xiangya Hospital of Central South University | 2022-01-01 |
| KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer (NCT05027867) | Kartos Therapeutics, Inc. | 2021-12-06 |
| A Phase II Study of Sintilimab Combined With Anlotinib in Treatment of ED-SCLC (NCT04967625) | Zhejiang Cancer Hospital | 2021-07-26 |
| Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer (NCT04670445) | Massachusetts General Hospital | 2021-01-23 |
| Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease (NCT04462276) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2020-07-28 |
| A Study of Fluzoparib Combined With Apatinib as Second-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer（FA-ES-SCLC） (NCT04659785) | Tianjin Medical University Second Hospital | 2020-07-01 |
| Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC (NCT03994744) | Hunan Cancer Hospital | 2019-08-20 |
| Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer (NCT03923270) | H. Lee Moffitt Cancer Center and Research Institute | 2019-06-06 |
| SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer (NCT03755115) | Henan Cancer Hospital | 2019-02-01 |
| Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer (NCT03325816) | Georgetown University | 2017-11-20 |
| Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer (NCT03253068) | Wakayama Medical University | 2017-08-01 |
| Immunotherapy as Second-line in Patient With Small Cell Lung Cancer (NCT03059667) | Intergroupe Francophone de Cancerologie Thoracique | 2017-03-13 |
| Molecular Analysis and Treatment Options of SCLC (NCT05945745) | Shanghai Chest Hospital | 2016-01-01 |
| Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC) (NCT02179528) | Peking University Cancer Hospital & Institute | 2014-09-01 |
| Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer (NCT00003496) | Burzynski Research Institute | 1996-03-07 |